Authors:
Stylianou, E
Aukrust, P
Muller, F
Nordoy, I
Froland, SS
Citation: E. Stylianou et al., Complex effects of interferon-alpha on the cytokine network in HIV infection - Possible contribution to immunosuppression, CYTOKINE, 14(1), 2001, pp. 56-62
Authors:
Friedland, JS
Constantin, D
Shaw, TC
Stylianou, E
Citation: Js. Friedland et al., Regulation of interleukin-8 gene expression after phagocytosis of zymosan by human monocytic cells, J LEUK BIOL, 70(3), 2001, pp. 447-454
Authors:
Stylianou, E
Aukrust, P
Nordoy, I
Muller, F
Froland, SS
Citation: E. Stylianou et al., Enhancement of lymphocyte proliferation induced by interleukin-12 and anti-interleukin-10 in HIV-infected patients during highly active antiretroviral therapy, APMIS, 108(9), 2000, pp. 601-607
Authors:
Stylianou, E
Aukrust, P
Bendtzen, K
Muller, F
Froland, SS
Citation: E. Stylianou et al., Interferons and interferon (IFN)-inducible protein 10 during highly activeanti-retroviral therapy (HAART) - possible immunosuppressive role of IFN-alpha in HIV infection, CLIN EXP IM, 119(3), 2000, pp. 479-485
Authors:
Ishikawa, Y
Sugiyama, H
Stylianou, E
Kitamura, M
Citation: Y. Ishikawa et al., Bioflavonoid quercetin inhibits interleukin-1-induced transcriptional expression of monocyte chemoattractant protein-1 in glomerular cells via suppression of nuclear factor-kappa B, J AM S NEPH, 10(11), 1999, pp. 2290-2296
Citation: E. Stylianou et al., c-Rel and p65 trans-activate the monocyte chemoattractant protein-1 gene in interleukin-1 stimulated mesangial cells, KIDNEY INT, 56(3), 1999, pp. 873-882
Authors:
Sugiyama, H
Savill, JS
Kitamura, M
Zhao, L
Stylianou, E
Citation: H. Sugiyama et al., Selective sensitization to tumor necrosis factor-alpha-induced apoptosis by blockade of NF-kappa B in primary glomerular mesangial cells, J BIOL CHEM, 274(28), 1999, pp. 19532-19537
Authors:
Stylianou, E
Aukrust, P
Kvale, D
Muller, F
Froland, SS
Citation: E. Stylianou et al., IL-10 in HIV infection: increasing serum IL-10 levels with disease progression - down-regulatory effect of potent anti-retroviral therapy, CLIN EXP IM, 116(1), 1999, pp. 115-120